Fidelity Investments’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-535,772
| Closed | -$12.7M | – | 4479 |
|
|
2019
Q3 | $12.7M | Buy |
535,772
+75
| +0% | +$1.77K | ﹤0.01% | 1747 |
|
|
2019
Q2 | $16.1M | Buy |
535,697
+68,863
| +15% | +$2.07M | ﹤0.01% | 1713 |
|
|
2019
Q1 | $10.5M | Buy |
466,834
+53,445
| +13% | +$1.2M | ﹤0.01% | 1848 |
|
|
2018
Q4 | $7.52M | Buy |
413,389
+338,801
| +454% | +$6.17M | ﹤0.01% | 1894 |
|
|
2018
Q3 | $1.35M | Sell |
74,588
-6,500
| -8% | -$118K | ﹤0.01% | 2438 |
|
|
2018
Q2 | $807K | Buy |
+81,088
| New | +$807K | ﹤0.01% | 2458 |
|